Top News Stories
The UK’s Addenbrooke's becomes the world’s first hospital to embrace Microsoft Azure-based artificial intelligence ...
As the second wave of the COVID-19 pandemic intensifies, with record numbers of cases and associated deaths, the ...
The first of two Phase 1 clinical trials, led by Mount Sinai Health System and sponsor Emergent BioSolutions (NYSE:
China State-Owned Sinopharm Tried to Charge the Philippines to Participate in Phase 3 Clinical Trial
TrialSite recently announced that China’s state-owned Sinopharm recently benefited from the conditional approval of
Dr. Vivek Datta, a neuropsychiatrist with University of California, San Francisco, recently shared on local media ...
A government-appointed panel of experts has apparently approved AstraZeneca’s COVID-19 vaccine --AZD1222, known as ...
As TrialSite has reported, Lilly’s Bamlanivimab (or LY-CoV555), despite its hi-tech nature as a monoclonal antibody
The results of a Phase 3 clinical trial evaluating the COVID-19 vaccine known as mRNA-1273 were published in the ...
Could it be that COVID-19 impacts the brain via microvascular blood vessel damage but not by direct viral ...
The Chinese life sciences market is on the move, and that means growth opportunities for contract research ...
China’s National Medical Products Administration announced that the first formal conditional approval for a ...
In an unacceptable quality error in the State of West Virginia, at least 42 people who were to receive the COVID-19
Popular Posts
